TY - JOUR
T1 - Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective
T2 - A qualitative study✰,✰✰,★,★★
AU - Lescoat, Alain
AU - Murphy, Susan L.
AU - Chen, Yen T.
AU - Vann, Nadia
AU - Galdo, Francesco Del
AU - Cella, David
AU - Buch, Maya H.
AU - Khanna, Dinesh
N1 - Funding Information:
★★ The project is funded by a grant by Scleroderma Raynaud UK/World Scleroderma Foundation ( UH&UHR1 ).
Funding Information:
✰ Funding: Dr. Chen is supported by a postdoctoral fellowship award funded by the University of Michigan ’s Advanced Rehabilitation Research Training Program in Community Living and Participation from the National Institute of Disability, Independent Living, and Rehabilitation Research, Administration for Community Living (grant # 90ARCP0003 );
Funding Information:
?Funding: Dr. Chen is supported by a postdoctoral fellowship award funded by the University of Michigan's Advanced Rehabilitation Research Training Program in Community Living and Participation from the National Institute of Disability, Independent Living, and Rehabilitation Research, Administration for Community Living (grant # 90ARCP0003);??Dr. Lescoat was funded by the French network of the University Hospitals HUGO (H?pitaux Universitaires du Grand Ouest) (AAP- GIRCI JCM2020) and a grant from Rennes University Hospital (CORECT Visiting Grant 2020).?Dr. Khanna's work was supported by the NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24-AR-063120).??The project is funded by a grant by Scleroderma Raynaud UK/World Scleroderma Foundation (UH&UHR1).
Funding Information:
★ Dr. Khanna's work was supported by the NIH /National Institute of Arthritis and Musculoskeletal and Skin Diseases ( K24-AR-063120 ).
Funding Information:
✰✰ Dr. Lescoat was funded by the French network of the University Hospitals HUGO (Hôpitaux Universitaires du Grand Ouest) (AAP- GIRCI JCM2020 ) and a grant from Rennes University Hospital (CORECT Visiting Grant 2020 ).
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2022/2
Y1 - 2022/2
N2 - Objectives: Limited cutaneous systemic sclerosis (lcSSc) is the largest subgroup of people with SSc, but little is known about symptom experience from the patients’ perspective. This study aimed to comprehensively identify domains and symptoms reported as bothersome by patients with lcSSc and to analyze themes and sub-themes capturing symptom experience in this population. Methods: Focus groups of patients with lcSSc were conducted using a structured guide. Patients were recruited based on an a priori purposive framework to include men and women with SSc. Focus groups were recorded, transcribed, anonymized, and analyzed using the RADaR technique (rigorous and accelerated data reduction) combined with iterative, deductive and inductive approaches. Results: Four 2-hour Focus groups comprising participants with lcSSc were conducted (N = 26). Ninety-four symptoms were identified with 22 domains. Symptoms from the following domains were mentioned in all Focus groups: skin, musculoskeletal (MSK), cardiac, pulmonary, gastro-intestinal (GI) manifestations, fatigue, sleep, Raynaud's phenomenon (RP), pain, and digital ulcers. The three most cited domains in a pre-meeting survey were GI, RP and MSK. Seven themes defining symptom experience were identified: difficulty attributing symptoms to this complex systemic disease, influence of symptom temporality, impairment of emotional well-being, limitations in functioning (including several sub-themes of functioning), survival, symptoms management and uncertainty. Conclusion: This study comprehensively identified domains and symptoms considered bothersome from the perspective of patients with lcSSc and summarized patient experience of lcSSc-related symptoms. This study is the first step in the design of a future combined response index dedicated to lcSSc that could foster specific research on this subpopulation of patients.
AB - Objectives: Limited cutaneous systemic sclerosis (lcSSc) is the largest subgroup of people with SSc, but little is known about symptom experience from the patients’ perspective. This study aimed to comprehensively identify domains and symptoms reported as bothersome by patients with lcSSc and to analyze themes and sub-themes capturing symptom experience in this population. Methods: Focus groups of patients with lcSSc were conducted using a structured guide. Patients were recruited based on an a priori purposive framework to include men and women with SSc. Focus groups were recorded, transcribed, anonymized, and analyzed using the RADaR technique (rigorous and accelerated data reduction) combined with iterative, deductive and inductive approaches. Results: Four 2-hour Focus groups comprising participants with lcSSc were conducted (N = 26). Ninety-four symptoms were identified with 22 domains. Symptoms from the following domains were mentioned in all Focus groups: skin, musculoskeletal (MSK), cardiac, pulmonary, gastro-intestinal (GI) manifestations, fatigue, sleep, Raynaud's phenomenon (RP), pain, and digital ulcers. The three most cited domains in a pre-meeting survey were GI, RP and MSK. Seven themes defining symptom experience were identified: difficulty attributing symptoms to this complex systemic disease, influence of symptom temporality, impairment of emotional well-being, limitations in functioning (including several sub-themes of functioning), survival, symptoms management and uncertainty. Conclusion: This study comprehensively identified domains and symptoms considered bothersome from the perspective of patients with lcSSc and summarized patient experience of lcSSc-related symptoms. This study is the first step in the design of a future combined response index dedicated to lcSSc that could foster specific research on this subpopulation of patients.
KW - Combined response index
KW - Domains
KW - Limited cutaneous systemic sclerosis
KW - Qualitative analysis
KW - Scleroderma
KW - Symptoms experience
UR - http://www.scopus.com/inward/record.url?scp=85118987026&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118987026&partnerID=8YFLogxK
U2 - 10.1016/j.semarthrit.2021.11.003
DO - 10.1016/j.semarthrit.2021.11.003
M3 - Article
C2 - 34785028
AN - SCOPUS:85118987026
SN - 0049-0172
VL - 52
JO - Seminars in Arthritis and Rheumatism
JF - Seminars in Arthritis and Rheumatism
M1 - 151926
ER -